Evidence map›Paper›PMID 40036896›Full record

ArticleAmerican journal of epidemiology2025

Allostatic load and cancer risk, progression, and mortality in epidemiologic studies.

Naoko Ishibe, Gary L Ellison, Divi Rao, Tram Kim Lam

Abstract read
In one paragraph

Article in American journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Naoko IshibeDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 9609 Medical Center Drive, Bethesda, MD, 20892, United States.ORCID 0000-0001-6651-9719
Gary L EllisonDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 9609 Medical Center Drive, Bethesda, MD, 20892, United States.ORCID 0000-0001-7325-7921
Divi RaoDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 9609 Medical Center Drive, Bethesda, MD, 20892, United States.ORCID 0000-0002-6873-2529
Tram Kim LamDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 9609 Medical Center Drive, Bethesda, MD, 20892, United States.ORCID 0000-0002-9192-2013

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current body of evidence from both preclinical and epidemiologic studies suggests that cumulative stress may play a role in carcinogenesis; however, few studies on human populations have examined allostatic load (AL) as it relates to cancer risk, progression, and mortality. In this commentary, we discuss the use and value of AL as a measure to assess exposure to stress for cancer epidemiologic studies, describe the existing evidence between AL and sources of cancer-related environmental stressors, and summarize the existing epidemiologic studies on AL and cancer risk, progression, and mortality. We also outline several knowledge gaps and what steps should be considered to advance research on the role of AL and cancer risk, progression, and mortality in human populations.

Indexed as

AllostasisNeoplasmsStress, PsychologicalDisease ProgressionEpidemiologic StudiesHumansRisk Factorsallostatic loadcancerenvironmental stressors

Identifiers

PMID40036896
PMCPMC13016672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.